EA200800101A1 - APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - Google Patents

APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Info

Publication number
EA200800101A1
EA200800101A1 EA200800101A EA200800101A EA200800101A1 EA 200800101 A1 EA200800101 A1 EA 200800101A1 EA 200800101 A EA200800101 A EA 200800101A EA 200800101 A EA200800101 A EA 200800101A EA 200800101 A1 EA200800101 A1 EA 200800101A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
application
neurodegenerative diseases
adrenoreceptor agonists
clenbuterol
Prior art date
Application number
EA200800101A
Other languages
Russian (ru)
Inventor
Йозеф Кригльштейн
Карстен Кульмзее
Вера Юнкер
Хельмут Блум
Вольфганг Греб
Original Assignee
Юкро Юропиан Контракт Рисерч Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10142175A external-priority patent/DE10142175A1/en
Priority claimed from DE10142176A external-priority patent/DE10142176A1/en
Priority claimed from DE10142178A external-priority patent/DE10142178A1/en
Priority claimed from DE10149611A external-priority patent/DE10149611A1/en
Application filed by Юкро Юропиан Контракт Рисерч Гмбх Унд Ко. Кг filed Critical Юкро Юропиан Контракт Рисерч Гмбх Унд Ко. Кг
Publication of EA200800101A1 publication Critical patent/EA200800101A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Заявлено применение кленбутерола - агониста β-адренорецепторов для восстановления и/или поддержания функции частично или полностью поврежденных/дегенерированных клеток в центральной нервной системе и/или других нервных клеток. Применение кленбутерола приводит к активации астроцитов и инициации эндогенных процессов нейрозащиты, причем оно может таким образом уменьшать и в некоторых случаях даже предупреждать повреждение или деструкцию нервных клеток.Clenbuterol, a β-adrenergic receptor agonist, is claimed to restore and / or maintain the function of partially or fully damaged / degenerated cells in the central nervous system and / or other nerve cells. The use of clenbuterol leads to the activation of astrocytes and the initiation of endogenous processes of neuroprotection, and it can thus reduce and in some cases even prevent damage or destruction of nerve cells.

EA200800101A 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES EA200800101A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10142175A DE10142175A1 (en) 2001-10-09 2001-08-29 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
DE10142176A DE10142176A1 (en) 2001-08-29 2001-08-29 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
DE10142178A DE10142178A1 (en) 2001-08-29 2001-08-29 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
DE10149611A DE10149611A1 (en) 2001-08-29 2001-10-09 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
EA200800101A1 true EA200800101A1 (en) 2008-06-30

Family

ID=40863263

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200400356A EA200400356A1 (en) 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
EA200800101A EA200800101A1 (en) 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA200400356A EA200400356A1 (en) 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Country Status (1)

Country Link
EA (2) EA200400356A1 (en)

Also Published As

Publication number Publication date
EA200400356A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
BR9712086A (en) Metalloproteinase1,4-heterocyclic inhibitors
ATE234092T1 (en) 2-ALKYLPYRROLIDINE
ID26033A (en) METHOD OF STABILIZATION OF PHARMACEUTICAL COMPOSITION MATERIALS WITH SPECIFIC USE OF ANTIOXIDE
ATE353640T1 (en) ANTAGONISTS FOR THE TREATMENT OF CD11/CD18 ADHESION RECEPTOR-MEDIATED DISEASES
DK1583541T3 (en) Compounds and Methods to Increase Neurogenesis
TR200001954T2 (en) Indole derivatives as inhibitors of factor XA.
DK0912176T3 (en) Use of pyridylalkane, pyridylalkene and / or pyridylalkynic acid amides for the treatment of tumors or immunosuppression
ATE428785T1 (en) ACTIVE AND INACTIVE CC CHEMOKINE RECEPTORS AND NUCLEIC ACID MOLECULES THAT CODE FOR THIS RECEPTOR
ATE358510T1 (en) DEVICE FOR IONTOPHORETIC ADMINISTRATION OF MEDICATION THROUGH THE EYELID
ATE362468T1 (en) N-SUBSTITUTED INDOLES WITH APPLICATION IN THE TREATMENT OF DIABETES
ATE324090T1 (en) ORTHOPICAL DEVICE FOR CORRECTING TOE MISPOINTMENTS
EA199800772A1 (en) Derivatives of 6-phenylpyridyl-2-amine
EA200200647A1 (en) Β2-adrenergic receptor agonists
ATE325119T1 (en) 3-SUBSTITUTED OXINDOLE BETA-3 AGONISTS
PT1379203E (en) CONDOM WITH AN ERGONOMIC COMPOSITION
PT1267869E (en) METABOTROPIC GLUTAMATE RECEPTOR ANTOGONISTS FOR THE TREATMENT OF TOLERANCE AND DEPENDENCE
HUP0203837A2 (en) Body weight gain inhibitors
ATE235422T1 (en) GELATION-STABLE POLYHALOGENPHOSPHAZENE COMPOUNDS
EA200800101A1 (en) APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
TR200101149T2 (en) Treatment of external retinal disorders.
DK0996435T3 (en) Amino acid derivatives useful for the treatment of stroke
PT1000046E (en) ACTIVE PIPERAZINE DERIVATIVES IN LOWER URINARY TRACT
DK1342410T3 (en) Use of a galanin agonist for the manufacture of a drug to improve memory and other cognitive functions
DK1056467T3 (en) Method of treating diseases or disorders of the inner ear
NO20062778L (en) Solid amorphous dispersions of an MTP inhibitor for the treatment of obesity